Please do not leave this page until complete. This can take a few moments.
With biotech laboratory space becoming scarce throughout Boston and Cambridge, Worcester and other Central Massachusetts locales should be ready to make themselves as attractive as possible to the companies and developers that could be looking wes
Ischemix LLC, a small Maynard biotech company, believes it has a promising solution to prevent the muscle damage caused by heart attacks and coronary surgery.
More and more businesses and elected officials are logging on to the micro-blog site Twitter to spread their message. Below is a roundup of local “tweets” from Central Massachusetts and Boston.
The market value of GTC Biotherapeutics Inc.'s stock has again spent 10 days at less than $35 million and out of compliance with Nasdaq Stock Market rules.
Framingham's GTC Biotherapeutics Inc. has struck an agreement to get $12.3 million from an existing shareholder, LFB Biotechnologies of France.
Marlborough-based Exact Sciences Corp. has received a $1 million loan from the Wisconsin Department of Commerce to relocate its headquarters and operations to Madison, Wisc.
Echo Therapeutics Inc. has signed a license agreement that allows a Korean drug company to develop and sell certain Echo products.
Christina Lampe-Onnerud, founder and CEO of Westborough-based Boston-Power Inc. has been named Ernst & Young's entrepreneur of the year for clean technology in the New England region.
Barry Quinlan, director of operations for the Littleton test facility of Bureau Veritas Consumer Products Services
The University of Massachusetts Medical School has named a team of four RNA experts, led by Nobel Laureate Craig C. Mello, to head its new RNA Therapeutics Institute.
Genzyme Corp. has temporarily halted production at its Allston Landing production facility after a virus that impairs cell growth was detected in one of six bioreactors there.
Oxford-based laser maker IPG Photonics said it has successfully tested a 10-kilowatt laser that is the largest of its kind.
Exact Sciences Corp. of Marlborough will work with the Mayo Clinic to develop noninvasive diagnostics for colorectal cancer under a new licensing and collaboration ag
Worcester's Advanced Cell Technology Inc. says its recent studies offer promising data about stem cell therapy to combat retinal disease.